AHSCT for relapsing remitting MS is currently available on the NHS in Scotland, Wales and England. It is offered at a small number of centres in England, but the number of people who are accepted for treatment is extremely small. AHSCT is not currently offered on the NHS for people with progressive MS.
People are usually only accepted if they continue to have relapses even after trying one or more of the disease modifying drugs. In addition, people with very aggressive MS, who have developed severe disability in the previous year, may be accepted for AHSCT.
You may be able to access AHSCT by taking part in a clinical trial, although you may be selected for the control or alternative treatment group rather than the AHSCT group. For example, the Star-MS clinical trial starting this year will recruit nearly 200 participants at 19 research centres around the UK. The study will compare highly effective disease modifying drugs with AHSCT over a 24 month period.
If you are considering AHSCT, whether through the NHS, a trial or privately, you would need to be referred by your usual neurologist or GP to the relevant team.
26 Nov 2021 - 00:00
Identifying mobility problems early on can be really helpful when it comes to preventative treatment and prolonging the use of certain muscles. In this article we talk to Jody Barber about common mobility problems in MS.
Ask the expert: speech problems
25 Nov 2021 - 00:00
We speak to a speech and language therapist to understand what causes speech problems and learn about some of the practical strategies that can help.
MS Trust funds a new MS nurse in north Wales
23 Nov 2021 - 00:00
Recently, the MS Trust was delighted to announce that we have funded an additional MS nurse to cover north Wales, through the Walton Centre, Liverpool. We chatted to Michelle and her fellow MS Nurse, Yvonne, about the difference the new role will make.
Sign up for updates from us
Keep up-to-date with the latest MS news, explore new research, read the stories of people living with MS, find out practical tips from MS experts, and discover exciting fundraising opportunities.